Cohen & Steers Inc. (CNS)
NYSE: CNS
· Real-Time Price · USD
75.42
-0.25 (-0.33%)
At close: Jun 16, 2025, 3:59 PM
75.40
-0.03%
After-hours: Jun 16, 2025, 05:05 PM EDT
-0.33% (1D)
Bid | 67.09 |
Market Cap | 3.85B |
Revenue (ttm) | 544.77M |
Net Income (ttm) | 157.04M |
EPS (ttm) | 3.06 |
PE Ratio (ttm) | 24.65 |
Forward PE | 21.42 |
Analyst | Hold |
Ask | 80.81 |
Volume | 90,782 |
Avg. Volume (20D) | 199,465 |
Open | 76.75 |
Previous Close | 75.67 |
Day's Range | 75.31 - 77.17 |
52-Week Range | 68.99 - 110.67 |
Beta | 1.32 |
Analyst Forecast
According to 0 analyst ratings, the average rating for CNS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+9.62%
Shares of capital market companies are trading hig...
Unlock content with
Pro Subscription
2 months ago
+2.6%
Shares of financial stocks are trading higher amid overall market strength on reports of potentially narrowed or targeted tariffs, which may be easing investor concerns.

1 month ago · businesswire.com
Alto Neuroscience to Participate in the JonesResearch Virtual CNS DayMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel pre...